Panagora Asset Management’s Jasper Therapeutics JSPR Stock Holding History

Panagora Asset Management’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.9K	Buy	21,543 +2,181	+11%	+$3.03K	﹤0.01%	1159
2025 Q4	$35.4K	Buy	+19,362	New	+$38.9K	﹤0.01%	1173
2021 Q3	–	Sell	-451	Closed	-$45K	–	2052
2021 Q2	$45K	Sell	451 -295	-40%	-$29.3K	﹤0.01%	2081
2021 Q1	$74K	Hold	746	–	–	﹤0.01%	2111
2020 Q4	$75K	Sell	746 -29	-4%	-$2.89K	﹤0.01%	1954
2020 Q3	$77K	Buy	+775	New	+$77.5K	﹤0.01%	1913

Other funds holding JSPR

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Panagora Asset Management's JSPR Position: Q1 2026 in Review

Panagora Asset Management increased its Jasper Therapeutics (JSPR) stake by 11% in Q1 2026, buying an estimated $3.03K and bringing the position to 21,543 shares worth $18.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

Panagora Asset Management first reported a position in JSPR in Q3 2020 and has held it in 6 quarters since. The position peaked at $77K in Q3 2020. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

Panagora Asset Management held 21,543 shares of Jasper Therapeutics worth $18.9K as of Q1 2026.
Panagora Asset Management bought 2,181 Jasper Therapeutics shares in Q1 2026, an estimated $3.03K.
Jasper Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #1159 holding.
Panagora Asset Management first reported a position in Jasper Therapeutics in Q3 2020 and has held it in 6 quarters since.
Panagora Asset Management's Jasper Therapeutics position peaked at $77K in Q3 2020.
58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.